Benzinga

JUNE 1, 2022

pharma giant Pfizer, Inc. What Happened: GSK said it is spinning off its consumer healthcare business into an independently-traded public company, named Haleon, a regulatory filing on Wednesday showed. GSK and Pfizer will hold about 6% and 32%, respectively, in Haleon. NYSE: PFE ). Full story available on Benzinga.com.

Dividends 98

Dividends 98

Law 360 M&A

MARCH 17, 2023

In this week's Taxation With Representation, Pfizer agreed to acquire Seagen, Silver Lake Capital and the Canada Pension Plan Investment Board said they'll acquire Qualtrics, Apollo Global Management Inc. affiliate-managed funds agreed to buy Univar Solutions Inc.,

75

75

Benzinga

AUGUST 8, 2022

Pfizer Inc. billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT ). Pfizer said it will pay $68.50 Global Blood shares ripped higher in midday trading on Friday after the Wall Street Journal reported Pfizer was in talks to acquire the company.

Banking 52

Banking 52

Benzinga

DECEMBER 13, 2022

Shares of Pfizer Inc. The company’s product pipeline and new launches offset the COVID-19 uncertainty in 2023, according to Goldman Sachs. The Analyst: Chris Shibutani upgraded the rating for Pfizer from Neutral to Buy, while raising the price target from $47 to $60. The Thesis: The New.

52

52

Business Wire M&A

MARCH 13, 2023

BUSINESS WIRE)--Pfizer Inc. NYSE: PFE) and Seagen Inc. The Boards of Directors of both companies have unanimously approved the transaction. Pfizer is dep NEW YORK & BOTHELL, Wash.--(BUSINESS

Enterprise Value 52

Enterprise Value 52

Benzinga

APRIL 7, 2022

Pfizer Inc (NYSE: PFE ) has agreed to acquire ReViral Ltd , a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics for the respiratory syncytial virus (RSV). Pfizer will pay up to $525 million, including upfront and development milestones.

52

52

Benzinga

JANUARY 6, 2023

Pfizer Inc (NYSE: PFE ) is reportedly exploring options for some early-stage candidates for rare diseases, including developing new viral-based gene therapies. Also see: Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues. Financial newspaper Barron's first reported on Thursday.

52

52

Benzinga

JANUARY 10, 2023

Coinbase Global, Inc (NASDAQ: COIN ) disclosed a restructuring plan letting go of 950 employees, helping it reduce its operating expenses by 25% amid the crypto meltdown. Taiwan Semiconductor Manufacturing Company Ltd's (NYSE: TSM ) December revenue of NT$192.56 Coinbase Bows Down To Macro Headwinds, To Let Go Of 950 Employees.

Start-ups 98

Start-ups Marketability 98

Benzinga

APRIL 28, 2023

Lucira Health Inc (OTC: LHDXQ ) has been acquired by Pfizer Inc (NYSE: PFE ) for $36.4 The company filed for bankruptcy in February, just two days before receiving FDA Emergency Use Authorization for the first over-the-counter (OTC) at-home diagnostic test to differentiate and detect influenza A and B.

52

52

Benzinga

MAY 10, 2022

Pfizer Acquires Biohaven For $11B. Pfizer Inc (NYSE: PFE ) will acquire Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN ) for $148.50 Praxis Precision Medicines Inc (NASDAQ: PRAX ) announced topline results from Part B of its Phase 2a study evaluating the safety and efficacy of PRAX-944 for essential tremors.

Marketability 97

Marketability Finance 97

Benzinga

MAY 10, 2022

Pfizer Inc (NYSE: PFE ) will acquire Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN ) for $148.50 Pfizer will also make payments at closing to settle Biohaven's third-party debt and for the redemption of all outstanding shares of Biohaven's redeemable preferred stock. per share , equivalent to $11.6

52

52

Benzinga

FEBRUARY 9, 2024

09, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR ) ("Better Choice" or "the Company"), a pet health and wellness company, today announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco Inc. NEW YORK, Feb. Aimia').

Marketability 45

Marketability 45

Benzinga

APRIL 7, 2022

Pfizer Inc (NYSE: PFE ) shares are trading higher Thursday. The company announced the acquisition of ReViral for a total consideration of up to $525 million. Sisunatovir has been.

52

52

Law 360 M&A

AUGUST 8, 2022

Pfizer Inc. will acquire sickle cell-drug company Global Blood Therapeutics in a $5.4 billion enterprise value deal shaped by legal advisers Cravath Swaine & Moore LLP, Goodwin Procter LLP and Wachtell Lipton Rosen & Katz, the companies said Monday.

Enterprise Value 40

Enterprise Value 40

Law 360 M&A

SEPTEMBER 9, 2022

Global Blood Therapeutics Inc. investors have challenged Pfizer's $5.4 billion plan to acquire the sickle cell-drug company, claiming that GBT's top brass made incomplete and misleading disclosures in an attempt to convince shareholders to sign off on the proposed deal.

40

40

Law 360 M&A

MAY 10, 2022

Pfizer Inc., billion, the companies said Tuesday. advised by Ropes & Gray LLP, plans to buy Sullivan & Cromwell LLP-led Biohaven Pharmaceuticals, a drugmaker known for developing migraine treatment, for about $11.6

40

40

Benzinga

OCTOBER 22, 2023

23, 2023 (GLOBE NEWSWIRE) -- Roivant (NASDAQ: ROIV ) announced today the entry into a definitive agreement with Roche ((SIX: RO, ROG, OTCQX: RHHBY ) to acquire Telavant Holdings, Inc. Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc. Frank Torti, M.D,

40

40

Reynolds Holding

APRIL 14, 2024

Typically, these cases involve a defendant who is an employee or agent of a company undertaking a takeover, and the defendant buys stock in the target of the takeover, using information that he learned from his client, the prospective bidder. Here, the two companies are linked in a transaction that is probably material to both.

Marketability 105

Marketability Banking 105

Benzinga

APRIL 7, 2022

Pharma giant Pfizer, Inc. The company announced a deal Thursday to buy privately held biopharma ReViral, which has a portfolio of antiviral therapeutic candidates, for up to $525 million. NYSE: PFE ), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

52

52

Benzinga

JANUARY 16, 2023

Key Industry Development: In an effort to diversify its product line, Pfizer Inc. purchased Arena, a company in the clinical stages of developing cutting-edge potential therapies for the treatment of immuno-inflammatory diseases. Pfizer Inc. Request a Sample Copy of the Research Report: [link].

Marketability 40

Marketability 40

Benzinga

JANUARY 22, 2023

Get a Sample Copy of the Research Report: [link] Companies Covered in Sorbitol Market Report are: Archer Daniels Midland Company Lonza Inc. SPI Pharma Roquette Frères Pfizer Inc. The aqueous solution acts as a suitable substitute as it replicates several properties of glycerol and glycols.

Marketability 40

Marketability 40

Benzinga

JUNE 22, 2023

8 million and approximately 21.3 % of the combined company BOSTON and NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. 8 million and approximately 21.3 % of the combined company BOSTON and NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. in May 2022.

Dividends 40

Dividends Finance 40

Benzinga

DECEMBER 7, 2022

Rising support from governments and several companies can help in the fight against this highly contagious disease. List of the Companies Operating in the Sugar Alcohol Market: Archer-Daniels-Midland Co. Pfizer Inc. – However, this too shall pass. There are some industries that are struggling and some are thriving.

Marketability 40

Marketability 40

Reynolds Holding

MARCH 28, 2022

Matthew Panuwat was a business development executive at Medivation Inc., an oncology-focused biopharmaceutical company. In this position, according to the SEC, he “closely tracked the stock prices, drug products and development pipelines of other biopharmaceutical companies.”. The SEC’s “Shadow Trading” Claim. was imminent.

Marketability 83

Marketability Banking Data Analysis Dividends 83

Benzinga

SEPTEMBER 6, 2022

Archer Daniels Midland Company (Illinois, U.S.). Pfizer Inc. Abbott (Illinois, U.S.). Nestle S.A. Vevey, Switzerland). Herbalife Nutrition Ltd. California, U.S.). Glanbia Nutritionals (Illinois, U.S.). Otsuka Holdings Co. Tokyo, Japan). Arkopharma (Carros, France). New York, U.S.). GlaxoSmithKline plc (Brentford, U.K.).

Marketability 40

Marketability 40

Benzinga

MAY 24, 2023

May 24, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. Pyxis Oncology") (NASDAQ: PYXS ), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, and Apexigen, Inc. ET BOSTON and SAN CARLOS, Calif., per Apexigen share.

Enterprise Value 52

Enterprise Value Technology 52

Benzinga

OCTOBER 26, 2022

Sumitovant), in conjunction with parent company Sumitomo Pharma Co., billion on a fully diluted basis, and a total company value of $2.9 On October 23, 2022, Sumitovant Biopharma Ltd. per share in cash. per share in cash. This corresponds to a total transaction value of $1.7 billion on a fully diluted basis. BASEL, Switzerland, Oct.

Start-ups 40

Start-ups Marketability Technology 40

Reynolds Holding

JULY 29, 2022

This post provides an overview of shareholder proposals submitted to public companies during the 2022 proxy season, [1] including statistics and notable decisions from the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) on no-action requests. [2]. Top Shareholder Proposals Submitted to Public Companies.

Equity 98

Equity Dividends Banking Finance 98

Reynolds Holding

MARCH 27, 2023

We examine developments in federal securities litigation involving special purpose acquisition companies. This figure is significantly lower than in 2016, when the Delaware Court of Chancery effectively put an end to the practice of disclosure-only settlements in In re Trulia Inc. Stockholder Litigation , 29 A.3d 3d 884 (Del.

Technology 59

Technology Start-ups Compliance Finance 59

Cooley M&A

JANUARY 22, 2021

COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in record-breaking time. An Evolving Transactional Landscape.

Marketability 40

Marketability Equity Technology 40

Reynolds Holding

FEBRUARY 1, 2023

A wide number of companies also announced separations, divestitures, carve-outs and spin-offs across industries over the course of the year, with over thirty $1 billion-plus divestitures and nearly forty spin-offs announced. Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6

Finance 45

Finance Equity Technology Banking 45